News

The El Paso Children's Hospital Foundation receives a $30,000 grant to support families with hospitalized children, covering non-medical needs.
The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology.
Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
Andersen Consulting enters into a Collaboration Agreement with BD Emerson, a leading consulting firm specializing in cybersecurity, compliance, privacy, and technology. BD Emerson delivers integrated ...
Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.
Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...